Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard-Dose TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease
NCT07510191Phase 4Recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of upadacitinib in Crohn's disease, sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Started Mar 2026; status: recruiting.
02
Drugs
upadacitinib
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT07510191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07510191.